Loading organizations...
Developing peptide-based compounds for metastatic squamous cancer.
amcure has raised $6.4M across 1 funding round.
amcure has raised $6.4M in total across 1 funding round.
amcure has raised $6.4M in total across 1 funding round.
amcure's investors include Harald Poth, Karlsruhe Institute of Technology, KfW, MBG Mittelstndische Beteiligungsgesellschaft Baden-Wrttemberg, S-Kap Unternehmensbeteiligungs.
amcure has raised $6.4M across 1 funding round. Most recently, it raised $6.4M Series B in December 2016.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 14, 2016 | $6.4M Series B | Harald Poth | Karlsruhe Institute of Technology, KfW, MBG Mittelstndische Beteiligungsgesellschaft Baden-Wrttemberg, S-Kap Unternehmensbeteiligungs |